| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/22/2007 | US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp) |
| 11/22/2007 | US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases |
| 11/22/2007 | US20070269378 Nadks as Modifiers of Branching Morphogenesis and Methods of Use |
| 11/22/2007 | US20070269355 Closed Reaction Vessel System |
| 11/22/2007 | US20070267301 Glucose Dehydrogenase/Cytochrome Fusion Protein |
| 11/22/2007 | US20070266775 Method for producing a biosensor |
| 11/22/2007 | DE112005002567T5 Eine neue Sonde und deren Verwendung in Bioaffinitäts-Analysen A new probe and its use in bioaffinity analyzes |
| 11/22/2007 | DE102006024058A1 Modular system for functionalization of sensor surface in medical analytics with biological active substance for producing DNA chip and micro arrays, comprises metallic surface on which nucleic acid and/or its derivatives are immobilized |
| 11/22/2007 | DE102006023906A1 Verfahren zum Nachweis der Viabilität A method of detecting the viability |
| 11/22/2007 | DE102006022569A1 Spezies-unabhängiges Nachweisverfahren für biologisches Material Species-independent detection method for biological material |
| 11/22/2007 | DE102006021406A1 In vitro Verfahren zur Erkennung und Früherkennung und zur begleitenden Kontrolle der Therapie von arznei- und suchtmittelinduzierten Leberschäden In vitro method for the detection and early detection and control for concomitant therapy of medicated and drug-induced liver injury |
| 11/22/2007 | DE102004049897B4 Verfahren zur Unterscheidung zwischen nichtinfektiösen und infektiösen Ursachen eines Multiorganversagens A method for distinguishing between non-infectious and infectious causes of multiple organ failure |
| 11/22/2007 | CA2687128A1 Compositions and methods for enzymatic treatment of lung disorders |
| 11/22/2007 | CA2676442A1 Methods for detection of target on responsive polymeric biochips |
| 11/22/2007 | CA2652455A1 Iap bir domain binding compounds |
| 11/22/2007 | CA2652452A1 Neutralizing antibodies to influenza viruses |
| 11/22/2007 | CA2652407A1 Electronic biosensor arrangement |
| 11/22/2007 | CA2652319A1 Identification and quantification of a plurality of biological (micro)organisms or their components |
| 11/22/2007 | CA2652258A1 Procedure and methods for detecting alzheimer's disease |
| 11/22/2007 | CA2652086A1 A general method for generating human antibody responses in vitro |
| 11/22/2007 | CA2652043A1 Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma |
| 11/22/2007 | CA2652011A1 Reaction chamber for real time pcr comprising capture probes and permitting detection of the pcr product by hybridisation without opening the pcr vessel |
| 11/22/2007 | CA2651954A1 Hla alleles associated with adverse drug reactions and methods for detecting such |
| 11/22/2007 | CA2651946A1 Compositions and methods to detect enterococci nucleic acid |
| 11/22/2007 | CA2651872A1 Detecting multiple types of leukocytes |
| 11/22/2007 | CA2651847A1 Detecting diastolic heart failure by protease and protease inhibitor plasma profiling |
| 11/22/2007 | CA2651839A1 Compositions and methods for inhibiting expression of the pcsk9 gene |
| 11/22/2007 | CA2651815A1 Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
| 11/22/2007 | CA2651805A1 Therapy |
| 11/22/2007 | CA2651758A1 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure |
| 11/22/2007 | CA2651755A1 Methods and compositions for the diagnosis and treatment of cancer |
| 11/22/2007 | CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 11/22/2007 | CA2651585A1 Thermostable dna polymerase of the archaeal ampullavirus abv and its applications |
| 11/22/2007 | CA2651510A1 Dna recombination junction detection |
| 11/22/2007 | CA2651419A1 Diagnostic methods for determining treatment |
| 11/22/2007 | CA2651051A1 Novel markers for prenatal diagnosis and monitoring |
| 11/22/2007 | CA2651049A1 New fetal methylation markers |
| 11/22/2007 | CA2650880A1 Abnormal output detection system for a biosensor |
| 11/22/2007 | CA2647102A1 Ras mutation and compositions and methods related thereto |
| 11/22/2007 | CA2643700A1 High throughput genome sequencing on dna arrays |
| 11/21/2007 | EP1857817A1 Screening method |
| 11/21/2007 | EP1857559A1 A method for predicting responsiveness to TNF alpha blocking agents |
| 11/21/2007 | EP1857555A1 Method for the production of a cell and/or tissue disease phase specific treatment |
| 11/21/2007 | EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 11/21/2007 | EP1857547A2 Further novel forms of interfering RNA molecules |
| 11/21/2007 | EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 11/21/2007 | EP1857465A1 Method of producing protein by using hamster igf-1 |
| 11/21/2007 | EP1857464A2 Chlamydia antigens |
| 11/21/2007 | EP1856537A1 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism |
| 11/21/2007 | EP1856527A2 Regulators of protein misfolding and aggregation and methods of using the same |
| 11/21/2007 | EP1856525A1 Disc substrates for combinatorial chemistry |
| 11/21/2007 | EP1856503A2 Dual path immunoassay device |
| 11/21/2007 | EP1856311A2 A method for identifying skin care composition-resistant skin-binding peptides |
| 11/21/2007 | EP1856298A2 Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv |
| 11/21/2007 | EP1856297A2 Method of detection of classical swine fever |
| 11/21/2007 | EP1856296A2 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 11/21/2007 | EP1856295A2 Compositions and methods for detecting viral specific nucleic acids in urine |
| 11/21/2007 | EP1856294A2 Key probe compositions and methods for polynucleotide detection |
| 11/21/2007 | EP1856293A2 Methods and compositions for assay readouts on multiple analytical platforms |
| 11/21/2007 | EP1856292A1 Diagnostic methods for identifying candidate patients for the treatment with trastuzumab. |
| 11/21/2007 | EP1856290A2 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 11/21/2007 | EP1856289A2 Predicting chemosensitivity to cytotoxic agents |
| 11/21/2007 | EP1856288A1 Forensic swab and kit |
| 11/21/2007 | EP1856287A2 Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| 11/21/2007 | EP1856286A2 Mir-155 assay |
| 11/21/2007 | EP1856285A2 Selection probe amplification |
| 11/21/2007 | EP1856284A1 Microarray with temperature specific controls |
| 11/21/2007 | EP1856283A2 Method for measuring and comparing the activity of biologically active compounds |
| 11/21/2007 | EP1856281A2 Gitr antibodies for the diagnosis of nsclc |
| 11/21/2007 | EP1856280A2 Compositions, methods, and kits for selective amplification of nucleic acids |
| 11/21/2007 | EP1856279A1 Method of diagnosing breast cancer and compositions therefor |
| 11/21/2007 | EP1856278A2 Method of diagnosing bladder cancer |
| 11/21/2007 | EP1856277A1 Marker solution to be applied by means of an inkjet printer |
| 11/21/2007 | EP1856276A1 Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors |
| 11/21/2007 | EP1856275A1 A method and kit for determination of thymidine kinase activity and use thereof |
| 11/21/2007 | EP1856274A2 Systemic markers for asthma and analogous diseases |
| 11/21/2007 | EP1856264A2 Expression cassettes for seed-preferential expression in plants |
| 11/21/2007 | EP1856257A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 11/21/2007 | EP1856256A2 Free reactant use in nucleic acid-templated synthesis |
| 11/21/2007 | EP1856254A1 Method for identifying pde11 modulators |
| 11/21/2007 | EP1856253A1 Method for identifying pde10 modulators |
| 11/21/2007 | EP1856239A1 Monitoring system for sensing microorganisms |
| 11/21/2007 | EP1856238A1 Viral diagnostic method and well for use in same |
| 11/21/2007 | EP1855595A2 Pharmaceutical liposomal compositions |
| 11/21/2007 | EP1751549B1 Orthodontic indicator |
| 11/21/2007 | EP1743038A4 Mn/ca ix/ ca9 and renal cancer prognosis |
| 11/21/2007 | EP1728074B1 Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension |
| 11/21/2007 | EP1680011A4 Determinationof phenotype of cancer and of precancerous tissue |
| 11/21/2007 | EP1654360B1 Amplification method |
| 11/21/2007 | EP1625233B1 Reducing microarray variation with internal reference spots |
| 11/21/2007 | EP1606303A4 Detection and monitoring of lung cancer |
| 11/21/2007 | EP1585972A4 Methods and compositions for diagnosing and monitoring transplant rejection |
| 11/21/2007 | EP1581660A4 Method of detecting dna single strand breaks |
| 11/21/2007 | EP1578904A4 Systems, methods and kits for remote genetic analysis and consultation |
| 11/21/2007 | EP1546355B1 Methods of use for thermostable rna ligases |
| 11/21/2007 | EP1525466A4 Transgenic mammals expressing polyglutamine |
| 11/21/2007 | EP1523564B1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 11/21/2007 | EP1492886A4 Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction |
| 11/21/2007 | EP1472518A4 Automatic threshold setting and baseline determination for real-time pcr |
| 11/21/2007 | EP1437402B1 Nucleic acid extracting device |